您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

SCITEK INTERNATIONAL (H.K.) LIMITED
Email: sciteck.hongkong@gmail.com
 

当前本网站药物产品种数共 8524 处方药 8148 非处方药 269 保健品/医疗用具 107

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 美国药房
产地国家: 美国
所属类别: 神经系统药物->抗抑郁药
处方药:处方药
包装规格: 100毫克/片 100片/盒
计价单位:
   
该药品相关信息网址1:
http://www.zoloft.com/
该药品相关信息网址2:
http://www.drugs.com/zoloft.html
该药品相关信息网址3:
http://www.rxlist.com/zoloft-drug.htm
原产地英文商品名:
SERTRALINE HCL TABLET(ZOLOFT GENERIC) 100mg/tab 100tabs/box
原产地英文药品名:
SERTRALINE HCL
中文参考商品译名:
盐酸舍曲林片剂(左洛复仿制药) 100毫克/片 100片/盒
中文参考药品译名:
盐酸舍曲林
中文参考化合物名称:
(1 S-顺式)-4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘啶胺盐酸盐
原产地国家批准上市年份:
0000/00/00
英文适应病症1:
Depression
英文适应病症2:
Obsessive-compulsive disorder
临床试验期:
完成
中文适应病症参考翻译1:
抑郁症
中文适应病症参考翻译2:
强迫症
药品信息:

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(20114618243935.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文盐酸舍曲林处方资料(仅供参考)

Zoloft---中文商品名:左洛复(郁乐复)
Zoloft---中文通用名:盐酸舍曲林
Zoloft是抗抑郁药!

【适应症】抑郁症,亦可用于治疗强迫症。

【用法用量】口服给药:
(1)抑郁症,一次50mg,一日1次,治疗剂量范围为一日50~100mg。
(2)强迫症,开始剂量为一次50mg,一日一次,逐渐增加至一日100~200mg,分次口服。

【不良反应】可有胃肠道不适,如恶心、厌食、腹泻等。亦可出现头痛、不安、无力、嗜睡、失眠、头晕或震颤等。少见不良反应有过敏性皮疹及性功能减退。大剂量时可能诱发癫痫。突然停药可有撤药综合症,如失眠、焦虑、恶心、出汗、震颤、眩晕或感觉异常等。
 
【注意事项】 
1.闭角型青光眼、癫痫病、严重心脏病患者慎用。
2.肝肾功能不全者慎用或减少用量。
3.出现转向躁狂发作倾向时应立即停药。
4.用药期间不宜驾驶车辆、操作机械或高空作业。              

【孕妇及哺乳期妇女用药】慎用。

【儿童用药】慎用。

【老年用药】酌情减少用量。

【药物相互作用】 
1.本品与单胺氧化酶抑制剂合用,可出现严重反应,在停用单胺氧化酶抑制剂14天内,不能服用本药;停用本品后也需14天以上才能开始单胺氧化酶抑制剂的治疗。
2.本品与色氨酸或芬氟拉明合用时,可使中枢神经系统对5-羟色胺的再摄取增加,出现药效学相互作用。
3.在舍曲林治疗期间不宜饮酒。
4.本品与西咪替丁合用,可降低舍曲林的清除。
5.本品与华法林合用,可延长凝血酶原时间。
6.本品与锂盐合用时,可能存在药效学相互作用,应慎用。

Indications for ZOLOFT
ZOLOFT is approved by the FDA to treat in adults Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder, Posttraumatic Stress Disorder (PTSD), Premenstrual Dysphoric Disorder (PMDD), and Social Anxiety Disorder. It is also approved to treat Obsessive-Compulsive Disorder (OCD) in children and adolescents aged 6-17 years.

IMPORTANT SAFETY INFORMATION
Suicidality and Antidepressant Drugs
Antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, and young adults especially within the first few months of treatment. Depression and certain other serious mental illnesses are important causes of suicidal thoughts and actions. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Anyone considering the use of ZOLOFT or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. ZOLOFT is not approved for use in pediatric patients except for patients with Obsessive-Compulsive Disorder (OCD).

Do not take ZOLOFT if you:
Take a Monoamine Oxidase Inhibitor (MAOI) or if you stopped taking an MAOI in the last 2 weeks. Do not take an MAOI within 2 weeks of stopping ZOLOFT. Ask your doctor or pharmacist if you are not sure if your medicine is an MAOI
Take Orap® (pimozide)
Are allergic to sertraline or any of the inactive ingredients in ZOLOFT
Do not take the ZOLOFT liquid formulation if you take Antabuse® (disulfiram) due to the alcohol content of the liquid form of ZOLOFT.

Tell your healthcare provider about all the medicines that you take including prescription and non-prescription medicine, vitamins, and herbal supplements.

Call a healthcare provider right away if you or a person you know who is taking ZOLOFT has any of the following symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying; attempts to commit suicide; new or worse depression; new or worse anxiety or panic attacks; feeling agitated, restless, angry or irritable; trouble sleeping; acting aggressive or violent; acting on dangerous impulses; an increase in activity or talking from what is normal for you (mania); or any other unusual changes in behavior or mood.

Tell your doctor immediately if you:
Become severely ill and have some or all of these symptoms: agitation, hallucinations, coma or other changes in mental status; coordination problems or muscle twitching (overactive reflexes); racing heartbeat, high or low blood pressure; sweating or fever; nausea, vomiting, or diarrhea; muscle tightness, as these may be the symptoms of a life-threatening condition called Serotonin Syndrome or Neuroleptic Malignant Syndrome
Have a rash, itchy welts (hives) or blisters, alone or with fever or joint pain; swelling of the face, tongue, eyes, or mouth; or trouble breathing, as these may be the symptoms of a severe allergic reaction
Have any increased or unusual bruising or bleeding, especially if you take the blood thinner warfarin (Coumadin®, Jantoven®), a non-steroidal anti-inflammatory drug (NSAID), or aspirin
Have a headache; weakness or feeling unsteady; confusion, problems concentrating, thinking, or remembering, as these may be the symptoms of low salt (sodium) levels in the blood (hyponatremia). Elderly people may be at greater risk for this

ZOLOFT can cause sleepiness or may affect your ability to make decisions, think clearly, or react quickly. You should not drive, operate heavy machinery, or do other dangerous activities until you know how ZOLOFT affects you.

Drinking alcohol while taking ZOLOFT is not recommended.

Women who are pregnant, plan to become pregnant, or who are breastfeeding should not take any antidepressant without consulting their doctor.

The most commonly observed adverse reactions in patients treated with ZOLOFT (seen in 5% or more of patients and at least twice as high as the control group) were nausea (25%), delayed ejaculation (14%), shakiness (8%), increased sweating (7%), lack of appetite (6%), and reduced sexual desire (6%).

In children and adolescents treated with ZOLOFT, adverse reactions were generally similar to adults. However, the following additional adverse reactions were reported in 2% or more of children/adolescents and at least twice as high as the control group: fever, hyperactivity, bedwetting, aggressive reaction, sinusitis, nosebleeds, and a bleeding sign resembling a bruise.

Do not stop ZOLOFT without first talking to your healthcare provider. Stopping ZOLOFT may cause serious symptoms including: anxiety, irritability, high or low mood, feeling restless or sleepy; headache, sweating, nausea, dizziness; electric shock-like sensations, tremor, and confusion.

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(20114618243935.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------

2011-4-7更新

更新日期: 2011-4-7
附件:
 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:sciteck.hongkong@gmail.com, 15901965168@163.com